BZYR — Burzynski Research Institute Share Price
0.000.00%
Last trade - 00:00- $5.43m
- $5.43m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 29th Feb | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Burzynski Research Institute, Inc. is engaged in the research, production, marketing, promotion and sale of certain medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives and organic acids which are known under the trade name Antineoplastons. Antineoplastons are useful in the treatment of human cancer and are reviewing data from its Phase II clinical trials of Antineoplastons relating to the treatment of various cancers. Antineoplastons are found in the bodily fluids of humans and food. The Company conducted all the Phase II clinical trials for the treatment of a variety of cancers using the combination of Antineoplastons A10 and AS2-1. Most of the trials involve the use of intravenous formulations of Antineoplastons; however, a few trials use oral formulations. The Company has not generated any operating revenue since its inception. The Company's clinical trials are conducted at the Burzynski Clinic.
Directors
- Stanislaw Burzynski CHM (78)
- Tomasz Janicki VPR (55)
- Patryk Goscianski TRS (43)
- Gregory Burzynski DRC (41)
- Carlton Hazlewood DRC (85)
- Monika Szopa - Paszkowiak DRC
- Last Annual
- February 29th, 2024
- Last Interim
- November 30th, 2024
- Incorporated
- January 4th, 1980
- Public Since
- October 15th, 2001
- No. of Employees
- 2
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 131,448,444
- Address
- 12000 Richmond Ave, HOUSTON, 77082
- Web
- http://burzynskiresearch.com/
- Phone
- +1 7133355697
- Auditors
- Pannell Kerr Forster of Texas, P.C.
Upcoming Events for BZYR
Q1 2026 Burzynski Research Institute Inc Earnings Release
Q2 2026 Burzynski Research Institute Inc Earnings Release
Similar to BZYR
Actavia Life Sciences
Pink Sheets on Nasdaq
Acura Pharmaceuticals
Pink Sheets on Nasdaq
Adhera Therapeutics
Pink Sheets on Nasdaq
Ramoil Management
Pink Sheets on Nasdaq
Adynxx
Pink Sheets on Nasdaq
FAQ
What is the Burzynski Research Institute share price?
As of Today at 19:44 UTC, shares in Burzynski Research Institute are trading at $0.04. This share price information is delayed by 15 minutes.
How has the Burzynski Research Institute share price performed this year?
Shares in Burzynski Research Institute last closed at $0.04 and the price had moved by -3.37% over the past 365 days. In terms of relative price strength the Burzynski Research Institute share price has underperformed the S&P500 Index by -10.4% over the past year.
What are the analyst and broker recommendations for Burzynski Research Institute?
There is no consensus recommendation for this security.
Find out moreWhat is the Burzynski Research Institute dividend yield?
Burzynski Research Institute does not currently pay a dividend.
Does Burzynski Research Institute pay a dividend?
Burzynski Research Institute does not currently pay a dividend.
When does Burzynski Research Institute next pay dividends?
Burzynski Research Institute does not currently pay a dividend.
How do I buy Burzynski Research Institute shares?
To buy shares in Burzynski Research Institute you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Burzynski Research Institute?
As of the previous close price of $0.04, shares in Burzynski Research Institute had a market capitalisation of $5.43m.
Where are Burzynski Research Institute shares listed?
Here are the trading details for Burzynski Research Institute:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: BZYR
What kind of share is Burzynski Research Institute?
Based on an overall assessment of its quality, value and momentum Burzynski Research Institute is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Burzynski Research Institute share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Burzynski Research Institute share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Burzynski Research Institute. Over the past six months, its share price has outperformed the S&P500 Index by +15.05%.
As of the last closing price of $0.04, shares in Burzynski Research Institute were trading -10.68% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Burzynski Research Institute PE Ratio?
The Burzynski Research Institute PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.04.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Burzynski Research Institute?
Burzynski Research Institute's management team is headed by:
- Stanislaw Burzynski - CHM
- Tomasz Janicki - VPR
- Patryk Goscianski - TRS
- Gregory Burzynski - DRC
- Carlton Hazlewood - DRC
- Monika Szopa - Paszkowiak - DRC